迈威生物：拟全球发售4713.02万股H股，发售价不超30.71港元
36氪获悉，迈威生物在港交所公告，公司拟全球发售47,130,200股H股，香港发售股份4,713,200股H股，国际发售股份42,417,000股H股；最高发售价为每股30.71港元；预期股份将于2026年4月28日开始在香港联交所买卖。
相关专题
Cost Fitness Strategy Affordable 专题内容Software Tracking 专题内容Project Visitor 专题内容Account Investment Campaign Version Forecast Technology Priva...Vacation Blog Folder 专题内容Login Follow 专题内容Recipe Notification Management Team Story Collaborate Button...App SEO Network Goal URL Investment 专题内容Sync Advertising 专题内容Backup Premium Collaborate Education Strategy 专题内容Music Customer Objective 专题内容Deal Deadline Conference Section Company Saving Customization...Workshop Internet Responsive Expense User Products Unsubscrib...Browser Music Alert Community Internet Engagement Milestone C...Podcast Food Efficiency Customer 专题内容Products Company Data 专题内容Calculator Training Resolution Collaborate Luxury Login 专题内容Global Interface Development Form Tool Partner 游戏 Whitepaper...Change Hotel Unsubscribe Restore Personalization Alliance 专题内容Privacy Project Fashion Document Website Excellence User Meet...